Pfizer Inc. (NYSE: PFE) has completed a double-blind, placebo-controlled, randomized clinical trial designed to assess the efficacy and safety of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE